Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma

Hematology/Oncology Clinics of North America

Volumn 17, Issue 3, 2003, Pages 785-820

  Knowles, Daniel M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; B LYMPHOCYTE ACTIVATION; BURKITT LYMPHOMA; CANCER LOCALIZATION; CANCER RISK; CELL LINEAGE; CLONOGENESIS; CYTOKINE RELEASE; EPSTEIN BARR VIRUS; GENE MUTATION; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOBLASTIC LYMPHOMA; IMMUNOPATHOGENESIS; LARGE CELL LYMPHOMA; LYMPHOCYTE PROLIFERATION; NONHODGKIN LYMPHOMA; ONCOGENE MYC; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0037710701     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(03)00050-9     Document Type: Review

References (203)

1. Elenitoba-Johnson KSJ, Jaffe ES. Lymphoproliferative disorders associated with congenital immunodeficiencies. Semin Diagn Pathol 1997;14:35-47.
2. Frizzera G. Atypical lymphoproliferative disorders. In: Knowles DM, editor. Neoplastic hematopathology. Philadelphia: Lippincott-Williams and Wilkins; 2001. p. 569-622.
3. Chadburn A, Cesarman E, Knowles DM. Molecular pathology of the post-transplantation lymphoproliferative disorders. Semin Diagn Pathol 1997;14:15-26.
4. Kamel OW. Iatrogenic Iymphoproliferative disorders in non-transplantation settings. Semin Diag Pathol 1997;14:27-34.
5. Doll D, List AF. Burkitt's lymphoma in a homosexual. Lancet 1982;i:1026.
6. Ziegler JL, Miner RC, Rosenbaum E, et al. Outbreak of Burkitt's like-lymphoma in homosexual men. Lancet 1982;ii:632.
7. Centers for Disease Control. Pneumocystis pneumonia - Los Angeles. MMWR Morb Mort Wkly Rep 1981;30:250.
8. Centers for Disease Control. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men-New York City and California. MMWR Morb Mort Wkly Rep 1981;30:305.
9. Centers for Disease Control. Revision of the case definition of acquired immuno-deficiency syndrome for national reporting - United States. MMWR Morb Mort Wkly Rep 1985; 34:373.
10. Ziegler JL, Beckstead JA, Volberding PA, et al. Non-Hodgkin's lymphoma in 90 homosexual men: relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 1984;311:565.
11. Levine AM, Meyer PR, Begandy MK, et al. Development of B cell lymphoma in homosexual men: clinical and immunologic findings. Ann Intern Med 1984;100:7.
12. Levine AM, Gill PS, Meyer PR, et al. Retrovirus and malignant lymphomas in homosexual men. JAMA 1985;254:1921.
13. Knowles DM, Chamulak GA, Subar M, et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS): the New York University experience. Ann Intern Med 1988;108:744.
14. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mort Wkly Rep 1987;36(Suppl):1S.
15. Beral V, Peterman T, Berkelman R, et al. AIDS-associated non-Hodgkin lymphoma. Lancet 1991;337:805.
16. Knowles DM, Chadburn A. Lymphadenopathy and the lymphoid neoplasms associated with the acquired immune deficiency syndrome. In: Knowles DM, editor. Neoplastic hematopathology. Philadelphia: Lippincott-Williams and Wilkins; 2001. p. 987-1089.
17. Levine AM, Sullivan-Halley J, Pike MC, et al. HIV-related lymphoma: prognostic factors predictive of survival. Cancer 1991;68:2466-72.
18. So YT, Beckstead JH, Davis RL. Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study. Ann Neurol 1986;20:566.
19. Biggar RJ, Curtis RE, Cote TR, et al. Risk of other cancers following Kaposi's sarcoma: relation to acquired immunodeficiency syndrome. Am J Epidemiol 1994;139:362-8.
20. Levine AM. Acquired immunodeficiency syndrome-related lymphoma. Blood 1992;80:8.
21. Biggar RJ, Rabkin CS. The epidemiology of AIDS-related neoplasms. Hematol Oncol Clin North Am 1996;10:997-1010.
22. Rabkin CS, Hilgartner MW, Hedberg KW, et al. Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia. JAMA 1992;267:1090-4.
23. Monfardini S, Vaccher E, Foa R, et al. AIDS-associated non-Hodgkin's lymphoma in Italy: intravenous drug users versus homosexual men. The Italian Cooperative Group on AIDS-Related Tumors (GICAT). Ann Oncol 1990;1:203.
24. Kaplan LD, Abrams DI, Feigal E, et al. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 1989;261:719.
25. Freter CE. Acquired immunodeficiency syndrome-associated lymphomas. J Natl Cancer Inst Monogr 1990;10:45-54.
26. Carbone A, Tirelli U, Vaccher E, et al. A clinicopathologic study of lymphoid neoplasias associated with human immunodeficiency virus infection in Italy. Cancer 1991;68:842.
27. Pedersen C, Gerstoft J, Lundgren JD, et al. HIV-associated lymphoma: histopathology and association with Epstein-Barr virus genome related to clinical, immunological and prognostic features. Eur J Cancer 1991;27:1416.
28. Ioachim HL, Dorsett B, Cronin W, et al. Acquired immunodeficiency syndrome associated lymphomas: clinical, pathological, immunologic and viral characteristics of 111 cases. Hum Pathol 1991;22:659.
29. Loureiro C, Gill PS, Meyer PR, et al. Autopsy findings in AIDS-related lymphoma. Cancer 1988; 62:735.
30. Levine AM, Gill PS. AIDS-related malignant lymphoma: clinical presentation and treatment approaches. Oncology 1987;1:41.
31. Burkes RL, Meyer PR, Gill PS, et al. Rectal lymphoma in homosexual men. Arch Intern Med 1986;146:913.
32. Gill PS, Chandraratna AN, Meyer PR, et al. Malignant lymphoma: cardiac involvement at initial presentation. J Clin Oncol 1987;5:216.
33. Ioachim HL, Ryan JR, Blaugrund S. Salivary gland lymph nodes: the site of lymphadenopathies and lymphomas associated with human immunodeficiency virus infection. Arch Pathol Lab Med 1988;112:1224.
34. Raphael J, Gentilhomme O, Tulliez M, et al. Histopathologic features of high grade non-Hodgkin's lymphomas in acquired immunodeficiency syndrome. Arch Pathol Lab Med 1991; 115:15.
35. Pollack RN, Sklarin NT, Rao S, et al. Metastatic placental lymphoma associated with maternal human immunodeficiency virus infection. Obstet Gynecol 1993;81:856-7.
36. Formenti SC, Gill PS, Lean E, et al. Primary central nervous system lymphoma in AIDS: results of radiation therapy. Cancer 1989;63:1101.
37. Gill PS, Graham RA, Boswell W, et al. A comparison of imaging, clinical and pathologic aspects of space occupying lesions within the brain in patients with acquired immunodeficiency syndrome. Am J Physiol Imaging 1986;1:134.
38. Goldstein JD, Dickson DW, Moser FG, et al. Primary central nervous system lymphoma in acquired immunodeficiency syndrome: a clinical and pathologic study with results of treatment with radiation. Cancer 1991;67:2756.
39. MacMahon EME, Glass JD, Hayward SD, et al. Epstein Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 1991;338:969.
40. Knowles DM, Inghirami G, Ubriaco A, Dalla-Favera R. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood 1989;73:792.
41. Walts AE, Shintaku IP, Said JW. Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement. Am J Clin Pathol 1990;94:170.
42. Karcher DS, Dawkins F, Garrett CT, Schulof RS. Body cavity-based non-Hodgkin's lymphoma (NHL) in HIV-infected patients: B-cell lymphoma with unusual clinical, immunophenotypic, and genotypic features [abstract]. Lab Invest 1992;66:80.
43. Green I, Espiritu E, Ladanyi M, et al. Primary lymphomatous effusions in AIDS: a morphological, immunophenotypic, and molecular study. Mod Pathol 1995;8:39.
44. Knowles DM, Dalla-Favera R. AIDS-associated malignant lymphoma. In: Broder S, Merrigan TC, Bolognesi D, editors. Textbook of AIDS medicine. Baltimore: Williams and Wilkins; 1994. p. 431.
45. Knowles DM. The pathology and the pathogenesis of non-Hodgkin's lymphomas associated with HIV infection. In: Magrath I, editor. The non-Hodgkin's lymphomas. London: Arnold; 1997. p. 471-94.
46. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences are present in AIDS-related body cavity based lymphomas. N Engl J Med 1995;332:1186.
47. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpesvirus. Blood 1996;88: 645-56.
48. Carbone A, Tirelli U, Gloghini A, et al. Herpesvirus-like DNA sequences selectively cluster with body cavity-based lymphomas throughout the spectrum of AIDS-related lymphomatous effusions. Eur J Cancer 1996;32A:555-6.
49. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
50. Raphael MM, Audouin J, Lamine M, et al. Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma: correlation with histologic features in 36 cases. Am J Clin Pathol 1994;101:773.
51. Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982;49:2112.
52. Carbone A, Gloghini A, Volpe R, et al, and the Italian Cooperative Group on AIDS and Tumors. High frequency of Epstein-Barr virus latent membrane protein-1 expression in acquired immnodeficiency syndrome-related Ki-1 (CD30)-positive anaplastic large cell lymphomas. Am J Clin Pathol 1994;101:768-72.
53. Tirelli U, Vaccher E, Zagonel V, et al. CD30 (Ki-1)-positive anaplastic large-cell lymphomas in 13 patients with and 27 patients without human immunodeficiency virus infection: the first comparative clinicopathologic study from a single institution that also includes 80 patients with other human immunodeficiency virus-related systemic lymphomas. J Clin Oncol 1995;13: 373-80.
54. Nador RG, Cesarman E, Knowles DM, Said JW. Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient. N Engl J Med 1995;333:943.
55. Said JW, Tasaka T, Takeuchi S, et al. Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood 1996;88:3124-8.
56. Ansari MQ, Dawson DB, Nador R, et al. Primary body cavity based AIDS-related lymphomas. Am J Clin Pathol 1996;105:221.
57. Gaidano G, Capello D, Cilia AM, et al. Genetic characterization of HHV-8/KSHV-positive primary effusion lymphoma reveals frequent mutations of BCL6: implications for disease pathogenesis and histogenesis. Genes Chromosomes Cancer 1999;24:16-23.
58. de Pond W, Said JW, Tasaka T, et al. Kaposi's sarcoma associated herpesvirus/human herpes-virus 8 (KSHV/HHV8)-associated lymphoma of the bowel: report of two cases in HIV-positive men with secondary effusion lymphomas. Am J Surg Pathol 1997;21:719-24.
59. Chadburn A, Cesarman E, Hyjek E, Liu YF, Milligan L, Said J, et al. Kaposi's sarcoma-associated herpesvirus positive extra-cavilary lymphomas in HIV-positive patients: part of the spectrum of primary effusion lymphoma [abstract]. Mod Pathol 2002;15:234A-5A.
60. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 1995;85:552.
61. Nador RG, Chadburn A, Gundappa G, Cesarman E, Said JW, Knowles DM. Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders. Am J Surg Pathol 2003;27:293-302.
62. Delecluse HJ, Anagnostopoulos F, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997; 89:1413-20.
63. Roithman R, Tourani JM, Andrieu JM. AIDS-associated non-Hodgkin's lymphoma. Lancet 1991;338:884.
64. Pelicci PG, Knowles DM, Arlin ZA, et al. Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders: implications for lymphomagenesis. J Exp Med 1986;164:2049.
65. Subar M, Neri A, Inghirami G, et al. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 1988;72:667.
66. Ballerini P, Gaidano G, Gong JZ, et al. Multiple genetic lesions in AIDS-related non-Hodgkin lymphoma. Blood 1993;81:166.
67. McGrath MS, Shiramizu B, Meeker TC, et al. AIDS-associated polyclonal lymphoma: identification of a new HIV-associated disease process. J Acquir Immune Defic Syndr 1991;4:408.
68. Meeker TC, Shiramizu B, Kaplan L, et al. Evidence for molecular subtypes of HIV-associated lymphoma: division into peripheral monoclonal, polyclonal and central nervous system lymphoma. AIDS 1991;5:669.
69. Shiramizu B, Herndier B, Meeker T, et al. Molecular and immunophenotypic characterization of AIDS-associated, Epstein-Barr virus-negative polyclonal lymphoma. J Clin Oncol 1992; 10:383.
70. Kaplan LD, Shiramizu B, Herndier B, et al. Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome. Blood 1995;85:1727-35.
71. Seiden M, Sklar J. AIDS and non-Hodgkin's lymphoma. A pre-pre-B cell monoclonal lymphoma versus a novel mechanism of polyclonality. J Clin Oncol 1992;10:1650.
72. Nador RG, Horenstein MG, Chadburn A, et al. Molecular analysis of 70 AIDS-related systemic non-Hodgkin's lymphomas from the east and west coasts of the United States of America (USA). Ann Oncol 1996;7(Suppl 3):16.
73. Knowles DM. The molecular pathology of AIDS-related non-Hodgkin's lymphoma. Semin Diagn Pathol 1997;14:67-82.
74. Tam W, Dalla-Favera R. Protooncogenes and tumor suppressor genes in hematopoietic malignancies. In: Knowles DM, editor. Neoplastic hematopathology. Philadelphia: Lippincott-Williams & Wilkins; 2001. p. 329-63.
75. Dalla-Favera R, Bregni M, Erikson J, et al. Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt's lymphoma cells. Proc Natl Acad Sci USA 1982; 79:7824-7.
76. Dalla-Favera R, Martinotti S, Gallor RC, et al. Translocation and rearrangement of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science 1983;219:963-7.
77. Croce CM, Nowell PC. Molecular genetics of human B cell neoplasia. Adv Immunol 1986;38: 245-74.
78. Delecluse HJ, Raphael M, Magaud JP, et al. Variable morphology of human immunodeficiency virus-associated lymphomas with c-myc rearrangements: the French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors. Blood 1993;82:552-63.
79. Carbone A, Tirelli U, Gloghini A, et al. Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. J Clin Oncol 1993;11:1674-81.
80. Carbone A, Gloghini A, Gaidano G, et al. AIDS-related Burkitt's lymphoma. Am J Clin Pathol 1995;103:561-7.
81. Rooney CM, Gregory CD, Rowe M, et al. Endemic Burkitt's lymphoma: phenotypic analysis of tumor biopsy cells and of derived tumor cell lines. J Natl Cancer Inst 1986;77:681-7.
82. Rowe M, Rowe DT, Gregory CD, et al. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 1987; 6:2743-51.
83. Gaidano G, Dalla-Favera R. Molecular pathogenesis of AIDS-related lymphomas. Antibiot Chemother 1994;46:117-24.
84. Magrath IT. Burkitt's lymphoma as a human tumor model: new concepts in etiology and pathogenesis. In: Pochedly C, editor, Pediatric heme/oncology reviews. New York: Praeger; 1985. p. 1.
85. Dalla-Favera R. Chromosomal translocations involving the c-myc oncogene and their role in the pathogenesis of B-cell neoplasia. In: Brugge J, Curran T, Harlow E, McCormick F, editors. Origins of human cancer. A comprehensive review. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1991. p. 543.
86. Shiramizu B, Barriga F, Neequaye J, et al. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. Blood 1991; 77:1516.
87. Lanfrancone L, Pelicci PG, Dalla-Favera R. Structure and expression of translocated c-myc oncogenes: specific differences in endemic, sporadic and AIDS-associated forms of Burkitt lymphomas. Curr Top Microbiol Immunol 1986;132:257.
88. Ye BH, Rao PH, Chaganti RSK, et al. Cloning of BCL-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res 1993;53:2732.
89. Ye BH, Lista F, Lo Coco F, et al. Alterations of a zinc-finger encoding gene, BCL-6, in diffuse large cell-lymphoma. Science 1993;262:747.
90. Ye BH, Cattoretti G, Shen Q, et al. The BCL-6 proto-oncogene controls germinal center formation and Th2-type inflammation. Nat Genet 1997;16:161-70.
91. Lo Coco F, Ye BH, Lista F, et al. Rearrangements of the BCL6 gene in diffuse large-cell non-Hodgkin's lymphoma. Blood 1994;83:1757.
92. Gaidano G, Lo Coco F, Ye BH, Shibata D, et al. Rearrangements of the BCL-6 gene in AIDS-associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype. Blood 1994; 84:397-402.
93. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1989;49:4682.
94. Neri A, Knowles DM, McCormick F, et al. Analysis of ras oncogene mutations in human lymphoid malignancies. Proc Natl Acad Sci USA 1988;85:9268.
95. Neri A, Baldini L, Ferrero D, et al. Frequency and type of ras oncogenes in lymphoid malignancies. In: Molecular diagnostics of human cancer. Cancer cells, vol. 7. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1989. p. 101.
96. Neri A, Murphy J, Cro L, et al. Ras oncogene mutation in multiple myeloma. J Exp Med 1989; 170:1715-25.
97. Seremetis S, Inghirami G, Ferrero D, et al. Transformation and plasmacytoid differentiation of EBV-infected human B lymphoblasts by ras oncogenes. Science 1989;243:660-3.
98. Raffeld M, Jaffe ES. bcl-1, t(11;14), and mantle cell-derived lymphomas. Blood 1991; 78:259.
99. Tsujimoto Y, Cossman J, Jaffe E, et al. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985;228:1440.
100. Weiss LM, Warnke RA, Sklar J, et al. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 1987;317:1185.
101. Levine AJ, Momand J, Finlay CA. The P53 tumor suppressor gene. Nature 1991;351:453.
102. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49.
103. Gaidano G, Ballerini P, Gong JZ, et al. p53 mutations in human lymphoid malignancies: association with Burkitt's lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1991;88:5413.
104. Cesarman E, Chadburn A, Inghirami G, et al. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T cell leukemia/lymphoma (ATLL) reveals frequent p53 mutations. Blood 1992;80:3205.
105. Gaidano G, Dalla-Favera R. Molecular pathogenesis of AIDS-related lymphomas. Adv Cancer Res 1995;67:113-53.
106. Dryja TP, Rapaport JM, Joyce JM, et al. Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastoma. Proc Natl Acad Sci USA 1986;83:7391-4.
107. Goodrich DW, Lee WH. The molecular genetics of retinoblastoma. Cancer Surv 1990;9:529.
108. Haber MM, Inghirami G, Dalla-Favera R, et al. Retinoblastoma (Rb) gene product expression in B cell non-Hodgkin's lymphomas (NHLs) and lymphoid leukemias (LLs) [abstract]. Lab Invest 1991;64:73a.
109. Offit K, Wong G, Filippa DA, et al. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations. Blood 1991;77:1508-15.
110. Gaidano G, Dalla-Favera R. Molecular biology of lymphoid neoplasms. In: Mendelsohn J, Howley PM, Israel MA, editors. The molecular basis of cancer. Philadelphia: WB Saunders; 1995. p. 251-72.
111. Hayashi Y, Raimondi SC, Look AT, et al. Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia. Blood 1990;76:1626-30.
112. Millikin D, Meese E, Vogelstein B, et al. Loss of heterozygocity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res 1991;51:5449-53.
113. Morita S, Saito S, Ishikawa J, et al. Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma. Cancer Res 1991;51:5817-20.
114. Offit K, Parsa NZ, Gaidano G, et al. 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood 1993;82:2157-62.
115. Baumgartner J, Rachlin J, Rosenblum M, et al. Patterns of gene rearrangement in AIDS-associated primary central nervous system lymphoma (PCNSL) [abstract]. Proc Am Soc Clin Oncol 1989;8:991.
116. Cesarman E, Knowles DM. Kaposi's sarcoma-associated herpes virus (KSHV/HHV -8): a lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma and multicentric Castleman's disease. Semin Diagn Pathol 1997;14:54-66.
117. Weinberg RA. Oncogenes, anti-oncogenes and the molecular bases of multistep carcinogenesis. Cancer Res 1989;49:3713.
118. Ganser A, Carlo-Stella C, Bartram CR, et al. Establishment of two Epstein-Barr virus negative Burkitt cell lines from a patient with AIDS and B-cell lymphoma. Blood 1988; 72:1255.
119. Gaidano G, Parsa NZ, Tassi V, et al. In vitro establishment of AIDS-related lymphoma cell lines: phenotypic characterization, oncogene and tumor suppressor gene lesions, and heterogeneity in Epstein-Barr virus infection. Leukemia 1993;7:162.
120. Shibata D, Brynes RK, Nathwani B, et al. Human immunodeficiency viral DNA is readily found in lymph node biopsies from seropositive individuals. Am J Pathol 1989;135:697.
121. Fauci AS, Schnittman SM, Poli G, et al. Immunopathogenetic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med 1991;114:678.
122. Lindahl T, Klein G, Reedman BM, et al. Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies. Int J Cancer 1974;13:764.
123. Klein G, Klein E. Evolution of tumors and the impact of molecular oncology. Nature 1985; 315:190.
124. Birx DI, Redfield RR, Tosato G. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med 1986;14:874-9.
125. Hamilton-Dutoit SJ, Pallesen G, Karkov J, et al. Identification of EBV-DNA in tumor cells of AIDS-related lymphomas by in-situ hybridization. Lancet 1989;i:554.
126. Hamilton-Dutoit SJ, Raphael M, Audouin J, et al. In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood 1993;82:619-24.
127. Neri A, Barriga F, Knowles DM, et al. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and AIDS-associated lymphoma. Blood 1991;77:1092.
128. Groopman JE, Sullivan JL, Mulder C, et al. Pathogenesis of B cell lymphoma in a patient with AIDS. Blood 1986;67:612.
129. Lombardi L, Newcomb EW, Dalla-Favera R. Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell 1987;49:161.
130. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985;43:831.
131. Beral V, Peterman TA, Berkelman RL, et al. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990;335:123-8.
132. Beral V. Epidemiology of Kaposi's sarcoma. In: Beral V, Jaffe HW, Weiss RA, editors. Cancer surveys: cancer, HIV and AIDS. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory; 1991. p. 5-22.
133. Peterman TA, Jaffe HW, Friedman-Kein AE, et al. The etiology of Kaposi's sarcoma. In: Beral V, Jaffe HW, Weiss RA, editors. Cancer surveys: cancer, HIV and AIDS. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory; 1991. p. 23-27.
134. Beral V, Bull D, Darby S, et al. Risk of Kaposi's sarcoma and sexual practices associated with fecal contact in homosexual or bisexual men with AIDS. Lancet 1992;339:632-5.
135. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865.
136. Lisitsyn N, Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science 1993;259:946.
137. Moore PS, Gao S-J, Dominguez G, et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J Virol 1996;70:549.
138. Cesarman E, Nador RG, Bai F, et al. KSHV/HHV-8 contains G protein-coupled receptor and cyclin D homologues which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol 1996;70:8218.
139. Boshoff C, Schulz TF, Kennedy MM, et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1995;1:1274-8.
140. Reed JA, Nador RG, Spaulding D, et al. Demonstration of Kaposi's sarcoma-associated herpesvirus cyclin D homolog in cutaneous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal amplification system. Blood 1998;91:2825-32.
141. Knowles DM, Cesarman E. The Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) in Kaposi's sarcoma, malignant lymphoma, and other diseases. Ann Oncol 1997;8(Suppl 2): 5123-9.
142. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995;346:799-802.
143. Karcher DS, Alkan S. Herpes-like DNA sequences. AIDS-related tumors, and Castleman's disease. N Engl J Med 1995;333:797-8.
144. Pastore C, Gloghini A, Volpe G, et al. Distribution of Kaposi's sarcoma herpesvirus sequences among malignancies in Italy and Spain. Br J Haematol 1995;91:918-20.
145. Mikol DM, Deplanche M, Moulinier A, et al. Herpes virus-like DNA sequences in primary non-Hodgkin's lymphomas of the central nervous system. J Neuropathol Exp Neurol 1996; 55:623.
146. Corboy JR, Garl PJ, Kleinschmidt-DeMasters BK. Human herpesvirus 8 DNA in CNS lymphomas from patients with and without AIDS. Neurol 1998;50:335-40.
147. Gaidano G, Capello D, Pastore C, et al. Analysis of human herpesvirus type 8 infection in AIDS-related and AIDS-unrelated primary central nervous system lymphoma. Am J Pathol 1996;149:1193-7.
148. Iuchi K, Ichimiya A, Akashi A, et al. Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Cancer 1987;60:1771.
149. Iuchi K, Aozasa K, Yamamoto S, et al. Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Summary of clinical and pathological findings in thirty-seven cases. Jpn J Clin Oncol 1989;19:249.
150. Cesarman E, Nador RG, Aozasa K, et al. Kaposi's sarcoma-associated herpesvirus in non-AIDS related lymphomas occurring in body cavities. Am J Pathol 1996;149:53.
151. Roizman B. Herpesviridae: A brief introduction. In: Fields BN, editor. Virology. New York: Raven Press, Ltd; 1990. p. 1787.
152. Fleckenstein B, Desrosiers RC. Herpesvirus saimiri and herpesvirus ateles. In: Roizman B, editor. The herpesviruses, vol. 1. New York: Plenum Press; 1982. p. 253.
153. Biesinger B, Muller-Fleckenstein J, Simmer B, et al. Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc Natl Acad Sci USA 1992;89:3116.
154. Tsujimoto Y, Finger LR, Yunis J, et al. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984;226:1097-9.
155. Jackson TR, Blair LA, Marshall J, et al. The mas oncogene encodes an angiotensin receptor. Nature 1988;335:437-40.
156. Motokura T, Bloom T, Kim HG, et al. A novel cyclin encoded by a bell-linked candidate oncogene. Nature 1991;350:512-5.
157. Zhang YJ, Jiang W, Chen CJ, et al. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 1993;196:1010-6.
158. Chang Y, Moore PS, Talbot SJ, et al. Cyclin encoded by Kaposi's sarcoma herpesvirus. Nature 1996;382:410.
159. Arvanitakis L, Geras-Raaka E, Gershengom MC, et al. Kaposi's sarcoma herpesvirus encodes a constitutively active G protein-coupled receptor linked to cell proliferation. Nature 1997;385: 347-50.
160. Mesri EA, Cesarman E, Arvanitakis L, et al. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med 1996;183: 2385-90.
161. Matolcsy A, Nador RG, Cesarman E, et al. Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphoma derive from different stages of B cell maturation. Am J Pathol 1998;153:1609-14.
162. Horenstein MG, Nador RG, Chadbum A, et al. Epstein-Barr virus latent gene expression in primary effusion lymhomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. Blood 1997;90:1186-91.
163. Karp JE, Broder S. Acquired immunodeficiency syndrome and non-Hodgkin's lymphomas. Cancer Res 1991;51:4743-56.
164. Pantaleo G, Graziosi C, Fauci AS. Mechanisms of disease: the immuno-pathogenesis of human immunodeficiency virus infection. N Engl J Med 1993;328:327.
165. Moore RD, Kessler H, Richman DD, et al. Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudine. JAMA 1991;265:2208-11.
166. Pluda JM, Venzon DJ, Tosato G, et al. Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving anti-retroviral therapy. J Clin Oncol 1993;11:1099-107.
167. Ramsay AD, Smith WJ, Isaacson PG. T-cell-rich B-cell lymphoma. Am J Surg Pathol 1988;12: 433-43.
168. List AF, Spier CM, Miller TP, et al. Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence. Leukemia 1993;7:398-403.
169. Moore MAS. The hematopoietic system and hematopoiesis. In: Knowles DM, editor. Neoplastic hematopathology. Philadelphia: Lippincott-Williams and Wilkins; 2001. p. 1-42.
170. Scala G, Quinto I, Ruocco MR, et al. Expression of an exogenous interleukin 6 gene in human Epstein-Barr virus B cells confers growth advantage and in vivo tumorigenicity. J Exp Med 1990; 172:61-8.
171. Tanner J, Tosato G. Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice. J Clin Invest 1991;88:239-47.
172. Yee C, Biondi A, Wang XH, et al. A possible autocrine role of IL-6 in two lymphoma cell lines. Blood 1989;74:789.
173. Kawano M, Hirano T, Matsuda T, et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 1988;332:83-5.
174. Nakajima K, Martinez-Maza O, Hirano T, et al. Induction of IL-6 (B cell stimulatory factor-2/ IFN-beta-2) production by human immunodeficiency virus. J Immunol 1989;142:531.
175. Emilie D, Peuchmaur M, Maillot MC, et al. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J Clin Invest 1990;86:148-59.
176. Birx DL, Redfield RR, Tencer K, et al. Induction of interleukin-6 during human immunodeficiency virus infection. Blood 1990;76:2303-10.
177. Breen EC, Rezai AR, Nakajima K, et al. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990;144:480-4.
178. Emile D, Coumbaras J, Raphael M, et al. Interleukin production in high-grade B lymphomas: correlation with presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus seronegative patients. Blood 1992;80:498.
179. Pluda JM, Venzon D, Tosato G, et al. Factors which predict for the development of non-Hodgkin's lymphoma in patients with HIV infection receiving antiretroviral therapy [abstract]. Blood 1991;78:285a.
180. Vieira P, de Waal-Malefyt R, Dang MN, et al. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRF1. Proc Natl Acad Sci USA 1991;88:1172-6.
181. Benjamin D, Knobloch TJ, Abrams J, et al. Human B cell IL-10: B cell lines derived from patients with AIDS and Burkitt's lymphoma constitutively secrete large quantities of IL-10 [abstract]. Blood 1991;78:384a.
182. Fiorentino DF, Zlotnik A, Vieira P, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991;146:3444-51.
183. de Waal Malefyt R, Haanen J, Spits H, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 1991;174:915-24.
184. Go BNF, Castle BE, Barrett R, et al. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J Exp Med 1990;172:1625-31.
185. Rousset F, Garcia E, Defrance T, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992;89:1890-3.
186. Schnittman SM, Lane HC, Higgins SE, et al. Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. Science 1986;233:1084.
187. Ng VL, Hwang KM, Reyes GR, et al. High titer anti-HIV antibody reactivity associated with a paraprotein spike in a homosexual male with AIDS related complex. Blood 1988;71:1397-401.
188. Ng VL, Chen KH, Kwang KM, et al. The clinical significance of human immunodeficiency virus type 1-associated paraproteins. Blood 1989;74:2471-5.
189. Bahler DW, Levy R. Clonal evolution of a follicular lymphoma: evidence for antigen selection. Proc Natl Acad Sci USA 1992;89:6770-4.
190. Zelenetz AD, Chen TT, Levy R. Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection. J Exp Med 1992;176:1137-48.
191. Riboldi P, Gaidano G, Schettino EW, et al. Two acquired immunodeficiency syndrome-associated Burkitt's lymphomas produce specific anti-i IgM cold agglutinins using somatically mutated VH4-21 segments. Blood 1994;83:2952-61.
192. Levine AM, Gill PS, Krailo M, et al. Natural history of persistent generalized lymphadenopathy (PGL) in gay men: risk of lymphoma and factors associated with development of lymphoma [abstract]. Blood 1986;68:130a.
193. Shibata D, Weiss LM, Nathwani BN, et al. Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma. Blood 1991;77:1527.
194. Alonso ML, Richardson ME, Metroka CE, et al. Chromosome abnormalities in AIDS-associated lymphadenopathy. Blood 1987;69:855.
195. Metroka CE, Cunningham-Rundles S, Pollack MS, et al. Generalized lymphadenopathy in homosexual men. Ann Intem Med 1983;99:585.
196. Mathur-Wagh U, Mildvan D, Senie RT. Follow-up at 4 1/2 years on homosexual men with generalized lymphadenopathy. N Engl J Med 1985;313:1542-3.
197. Adams JM, Harris AW, Pinkert CA, et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985;318:533.
198. Laurence J, Astrin SM. Human immunodeficiency virus induction of malignant transformation in human B lymphocytes. Proc Natl Acad Sci USA 1991;88:7635.
199. Pauza CD, Galindo J, Richman DD. Human immunodeficiency virus infection of monoblastoid cells: Cellular differentiation determines the pattern of virus replication. J Virol 1988;62:3558.
200. Inghirami G, Grignani F, Stemas L, et al. Down-regulation of LFA-1 adhesion receptors by c-myc oncogene in human B lymphoblastoid cells. Science 1990;250:682.
201. Clayberger C, Wright A, Medeiros LJ, et al. Absence of cell surface LFA-1 as a mechanism of escape from immunosurveillance. Lancet 1987;2:533.
202. Inghirami G, Wieczorek R, Zhu BY, et al. Differential expression of LFA-1 molecules in non-Hodgkin's lymphoma and lymphoid leukemia. Blood 1988;72:1431.
203. Bernstein L, Hamilton AS. The epidemiology of AIDS-related malignancies. Curr Opin Oncol 1993;5:822-30.